


The Group featured in “Top100 Chinese Chemical Pharmaceutical Companies Ranking”, with its product winning award again
最新消息The 2024 China Medical and Health Industry Symbiosis Conference, organized by Menet, a healthcare information platform, was grandly held in Huzhou...

The Group’s in-house developed product Adapalene and Clindamycin Hydrochloride Gel was successfully launched
最新消息May 30, 2024, Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”, HKEx:00950) grandly held the launch ceremony at...

The Group’s in-licensed products INOmax® and INOmax DSIR Plus were successfully launched
最新消息Recently, the "Symposium on the Progress of Nitric Oxide Inhalation Therapy in Newborns" organized by the Shanghai Caritas Foundation...

Lee’s Pharmaceutical participated in the 88th PharmChina
最新消息May 15, 2024, the high-profile 88th PharmChina was grandly opened at the Shanghai National Exhibition and Convention Center...

Zhaoke-Hefei was honored with the “Safe Enterprise” title in Hefei for the year 2023
最新消息Recently, the Hefei Municipal Department of Economy and Information Technology announced the list of “Safe Enterprises”...

Azilsartan Tablets won the “Guangdong Prominent High-tech Products” award
最新消息Recently, the Guangdong High-tech Association granted the certificates of “Guangdong Prominent High-tech Products” for 2023...

The Group featured in “Top100 Chinese Chemical Pharmaceutical Companies Ranking”, with its product winning award again
最新消息The 2024 China Medical and Health Industry Symbiosis Conference, organized by Menet, a healthcare information platform, was grandly held in Huzhou...

The Group’s in-house developed product Adapalene and Clindamycin Hydrochloride Gel was successfully launched
最新消息May 30, 2024, Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”, HKEx:00950) grandly held the launch ceremony at...

The Group’s in-licensed products INOmax® and INOmax DSIR Plus were successfully launched
最新消息Recently, the "Symposium on the Progress of Nitric Oxide Inhalation Therapy in Newborns" organized by the Shanghai Caritas Foundation...

Lee’s Pharmaceutical participated in the 88th PharmChina
最新消息May 15, 2024, the high-profile 88th PharmChina was grandly opened at the Shanghai National Exhibition and Convention Center...

Zhaoke-Hefei was honored with the “Safe Enterprise” title in Hefei for the year 2023
最新消息Recently, the Hefei Municipal Department of Economy and Information Technology announced the list of “Safe Enterprises”...

Azilsartan Tablets won the “Guangdong Prominent High-tech Products” award
最新消息Recently, the Guangdong High-tech Association granted the certificates of “Guangdong Prominent High-tech Products” for 2023...

The Group featured in “Top100 Chinese Chemical Pharmaceutical Companies Ranking”, with its product winning award again
最新消息The 2024 China Medical and Health Industry Symbiosis Conference, organized by Menet, a healthcare information platform, was grandly held in Huzhou...

The Group’s in-house developed product Adapalene and Clindamycin Hydrochloride Gel was successfully launched
最新消息May 30, 2024, Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”, HKEx:00950) grandly held the launch ceremony at...

The Group’s in-licensed products INOmax® and INOmax DSIR Plus were successfully launched
最新消息Recently, the "Symposium on the Progress of Nitric Oxide Inhalation Therapy in Newborns" organized by the Shanghai Caritas Foundation...

Lee’s Pharmaceutical participated in the 88th PharmChina
最新消息May 15, 2024, the high-profile 88th PharmChina was grandly opened at the Shanghai National Exhibition and Convention Center...

Zhaoke-Hefei was honored with the “Safe Enterprise” title in Hefei for the year 2023
最新消息Recently, the Hefei Municipal Department of Economy and Information Technology announced the list of “Safe Enterprises”...